Hyundai Bioscience Co. Ltd (048410) — Cash Flow Reinvestment Rate
Hyundai Bioscience Co. Ltd (048410) has a Cash Flow Reinvestment Rate of 1.11x as of December 2024, reinvesting ₩2.52 Billion (capex ₩2.17 Billion plus investments ₩-345.74 Million) from operating cash flow of ₩2.26 Billion. See free cash flow generation of Hyundai Bioscience Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hyundai Bioscience Co. Ltd Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Hyundai Bioscience Co. Ltd across 8 annual periods. For the full cash flow conversion analysis, see Hyundai Bioscience Co. Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Hyundai Bioscience Co. Ltd (2008–2024)
Year-by-year capital reinvestment analysis for Hyundai Bioscience Co. Ltd. See financial flexibility index of Hyundai Bioscience Co. Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 9.71x | ₩21.91 Billion | ₩2.26 Billion | ₩2.17 Billion | ▲ +178.5% |
| 2020 | 3.49x | ₩26.15 Billion | ₩7.50 Billion | ₩25.20 Billion | ▲ +433.9% |
| 2019 | 0.65x | ₩5.99 Billion | ₩9.18 Billion | ₩3.07 Billion | ▼ -67.3% |
| 2018 | 2.00x | ₩9.99 Billion | ₩5.01 Billion | ₩7.07 Billion | ▼ -95.2% |
| 2015 | 41.75x | ₩3.65 Billion | ₩87.36 Million | ₩647.57 Million | ▲ +3034.7% |
| 2014 | 1.33x | ₩1.63 Billion | ₩1.22 Billion | ₩840.18 Million | ▲ +1874.4% |
| 2011 | 0.07x | ₩267.78 Million | ₩3.97 Billion | ₩267.78 Million | ▼ -82.1% |
| 2008 | 0.38x | ₩3.92 Billion | ₩10.37 Billion | ₩3.92 Billion | — |